High levels of very long-chain saturated fatty acid in erythrocytes correlates with atherogenic lipoprotein profiles in subjects with metabolic syndrome

Diabetes Research and Clinical Practice

Volumn 99, Issue 1, 2013, Pages 12-18

  Matsumori, Rie ^a   Miyazaki, Tetsuro ^a   Shimada, Kazunori ^a   Kume, Atsumi ^a   Kitamura, Yohei ^b   Oshida, Kyoichi ^c   Yanagisawa, Naotake ^b   Kiyanagi, Takashi ^a   Hiki, Makoto ^a   Fukao, Kosuke ^a   Hirose, Kuniaki ^a   Ohsaka, Hiromichi ^a   Mokuno, Hiroshi ^a   Daida, Hiroyuki ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MORINAGA MILK INDUSTRY CO LTD   (Japan)

^c Kemin Industries Inc   (United States)

Author keywords

Atherogenic lipoproteins; Inflammation; Metabolic syndrome; Peroxisomal dysfunction; Saturated very long chain fatty acid

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LIGNOCERIC ACID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LONG CHAIN FATTY ACID;

ADULT; ARTICLE; ATHEROGENESIS; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; ERYTHROCYTE; FATTY ACID BLOOD LEVEL; GAS LIQUID CHROMATOGRAPHY; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPID COMPOSITION; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; PARTICLE SIZE; PROTEIN ANALYSIS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ERYTHROCYTES; FATTY ACIDS; FLAME IONIZATION; HUMANS; JAPAN; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOLECULAR WEIGHT; PARTICLE SIZE; RISK FACTORS;

EID: 84870976445     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.10.025     Document Type: Article

References (35)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001, 285:2486-2497.
2. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480.
3. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683-689.
4. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709-2716.
5. Mottillo S., Filion K.B., Genest J., Joseph L., Pilote L., Poirier P., et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010, 56:1113-1132.
6. Vessby B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr Opin Lipidol 2003, 14:15-19.
7. Laaksonen D.E., Lakka T.A., Lakka H.M., Nyyssonen K., Rissanen T., Niskanen L.K., et al. Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet Med 2002, 19:456-464.
8. Antoku Y., Tsukamoto K., Miyoshi Y., Nagino H., Anezaki M., Suwa K., et al. Correlations of elevated levels of hexacosanoate in erythrocyte membranes with risk factors for atherosclerosis. Atherosclerosis 2000, 153:169-173.
9. Kume A., Miyazaki T., Kitamura Y., Oshida K., Yanagisawab N., Takizawa H., et al. High levels of saturated very long-chain fatty acid (hexacosanoic acid; C26:0) in whole blood are associated with metabolic syndrome in Japanese men. Diabetes Res Clin Pract 2008, 80:259-264.
10. Yanagisawa N., Shimada K., Miyazaki T., Kume A., Kitamura Y., Ichikawa R., et al. Polyunsaturated fatty acid levels of serum and red blood cells in apparently healthy Japanese subjects living in an urban area. J Atheroscler Thromb 2010, 17:285-294.
11. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
12. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
13. Usui S., Hara Y., Hosaki S., Okazaki M. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J Lipid Res 2002, 43:805-814.
14. Miyazaki T., Shimada K., Miyauchi K., Kume A., Tanimoto K., Kiyanagi T., et al. Effects of fenofibrate on lipid profiles, cholesterol ester transfer activity, and in-stent intimal hyperplasia in patients after elective coronary stenting. Lipids Health Dis 2010, 9:122.
15. Poirier Y., Antonenkov V.D., Glumoff T., Hiltunen J.K. Peroxisomal beta-oxidation - a metabolic pathway with multiple functions. Biochim Biophys Acta 2006, 1763:1413-1426.
16. Van Veldhoven P.P. Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism. J Lipid Res 2010, 51:2863-2895.
17. Whitcomb R.W., Linehan W.M., Knazek R.A. Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro. J Clin Invest 1988, 81:185-188.
18. Ho J.K., Moser H., Kishimoto Y., Hamilton J.A. Interactions of a very long chain fatty acid with model membranes and serum albumin implications for the pathogenesis of adrenoleukodystrophy. J Clin Invest 1995, 96:1455-1463.
19. Dhaunsi G.S., Kaur J., Alsaeid K., Turner R.B., Bitar M.S. Very long chain fatty acids activate NADPH oxidase in human dermal fibroblasts. Cell Biochem Funct 2005, 23:65-68.
20. Singh J., Khan M., Singh I. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes. J Lipid Res 2011, 52:2056-2069.
21. Perichon R., Bourre J.M., Kelly J.F., Roth G.S. The role of peroxisomes in aging. Cell Mol Life Sci 1998, 54:641-652.
22. Kou J., Kovacs G.G., Hoftberger R., Kulik W., Brodde A., Forss-Petter S., et al. Peroxisomal alterations in Alzheimer's disease. Acta Neuropathol 2011, 122:271-283.
23. Ofman R., Dijkstra I.M., van Roermund C.W., Burger N., Turkenburg M., van Cruchten A., et al. The role of Elovl1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy. EMBO Mol Med 2010, 2:90-97.
24. Jakobsson A., Westerberg R., Jacobsson A. Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res 2006, 45:237-249.
25. Zadravec D., Brolinson A., Fisher R.M., Carneheim C., Csikasz R.I., Bertrand-Michel J., et al. Ablation of the very-long-chain fatty acid elongase Elovl3 in mice leads to constrained lipid storage and resistance to diet-induced obesity. FASEB J 2010, 24:4366-4377.
26. Miyazaki T., Shimada K., Sato O., Kotani K., Kume A., Sumiyoshi K., et al. Circulating malondialdehyde-modified LDL and atherogenic lipoprotein profiles measured by nuclear magnetic resonance spectroscopy in patients with coronary artery disease. Atherosclerosis 2005, 179:139-145.
27. Grundy S.M. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2004, 89:2595-2600.
28. Hansel B., Giral P., Nobecourt E., Chantepie S., Bruckert E., Chapman M.J., et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 2004, 89:4963-4971.
29. Mauger J.F., Lichtenstein A.H., Ausman L.M., Jalbert S.M., Jauhiainen M., Ehnholm C., et al. Effect of different forms of dietary hydrogenated fats on LDL particle size. Am J Clin Nutr 2003, 78:370-375.
30. Rice B.H., Kraft J., Destaillats F., Bauman D.E., Lock A.L. Ruminant-produced trans-fatty acids raise plasma total and small HDL particle concentrations in male hartley guinea pigs. J Nutr 2010, 140:2173-2179.
31. Kratz M., Gulbahce E., von Eckardstein A., Cullen P., Cignarella A., Assmann G., et al. Dietary mono- and polyunsaturated fatty acids similarly affect LDL size in healthy men and women. J Nutr 2002, 132:715-718.
32. Tsuda K. Oxidative stress and membrane fluidity of red blood cells in hypertensive and normotensive men: an electron spin resonance investigation. Int Heart J 2010, 51:121-124.
33. Tsuda K. Roles of adiponectin and oxidative stress in the regulation of membrane microviscosity of red blood cells in hypertensive men-an electron spin resonance study 2011. J Obes 2011.
34. Yanagisawa N., Shimada K., Miyazaki T., Kume A., Kitamura Y., Sumiyoshi K., et al. Enhanced production of nitric oxide, reactive oxygen species, and pro-inflammatory cytokines in very long chain saturated fatty acid-accumulated macrophages. Lipids Health Dis 2008, 7:48.
35. Assies J., Pouwer F., Lok A., Mocking R.J., Bockting C.L., Visser I., et al. Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study. PLoS ONE 2010, 5:e10635.